Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs
Version 2 2024-06-05, 05:09
Version 1 2023-10-26, 04:26
journal contribution
posted on 2023-10-26, 04:26 authored by B Kanchanatawan, S Sirivichayakul, A F Carvalho, G Anderson, P Galecki, Michael MaesDepressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs
History
Journal
Progress in Neuro-Psychopharmacology and Biological PsychiatryVolume
80Pagination
205 - 216Location
Amsterdam, The NetherlandsPublisher DOI
ISSN
0278-5846eISSN
1878-4216Language
engPublication classification
C1 Refereed article in a scholarly journalUsage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineClinical NeurologyNeurosciencesPharmacology & PharmacyPsychiatryNeurosciences & NeurologySchizophreniaDepressionAnxietyImmuneInflammationIndoleamine 2,3-dioxygenaseKynurenineKYNURENINE PATHWAYCEREBROSPINAL-FLUIDBIPOLAR DISORDERRATING-SCALENITROSATIVE DAMAGEPLASMA TRYPTOPHANIMMUNE-RESPONSEHEPATITIS-CACID
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC